FTSE 350 Review 2018 

FTSE 350: Look overseas for healthcare opportunities in 2018

FTSE 350: Look overseas for healthcare opportunities in 2018

South Africa-based private hospital operator Mediclinic(MDC) hasn’t made a secret of its intentions to enter the UK healthcare market. In 2017, that desire manifested itself via an (unsuccessful) bid for British rival Spire (SPI), which had seen its share price hammered by a combination of poor financial performance and unfortunate reputational damage. But Mediclinic might be better off focusing on the Middle East, a market where it already has a footprint and which looks increasingly more attractive than the UK healthcare market.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now